The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
• Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive m...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Kerr, Keith M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
15 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation - Garrote, Pedro J. ELSEVIER, 2019, journal of the International Association for the Study of Lung Cancer, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:154 ; year:2021 ; pages:161-175 ; extent:15 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.lungcan.2021.02.026 |
|---|
| Katalog-ID: |
ELV053579305 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV053579305 | ||
| 003 | DE-627 | ||
| 005 | 20230624195827.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2021.02.026 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica |
| 035 | |a (DE-627)ELV053579305 | ||
| 035 | |a (ELSEVIER)S0169-5002(21)00086-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kerr, Keith M. |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The evolving landscape of biomarker testing for non-small cell lung cancer in Europe |
| 264 | 1 | |c 2021 | |
| 300 | |a 15 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. | ||
| 650 | 7 | |a ALK |2 Elsevier | |
| 650 | 7 | |a ASCO |2 Elsevier | |
| 650 | 7 | |a RET |2 Elsevier | |
| 650 | 7 | |a SGT |2 Elsevier | |
| 650 | 7 | |a FDA |2 Elsevier | |
| 650 | 7 | |a NCCN |2 Elsevier | |
| 650 | 7 | |a IHC |2 Elsevier | |
| 650 | 7 | |a TAT |2 Elsevier | |
| 650 | 7 | |a NEQAS |2 Elsevier | |
| 650 | 7 | |a OncoKB |2 Elsevier | |
| 650 | 7 | |a QuIP |2 Elsevier | |
| 650 | 7 | |a ctDNA |2 Elsevier | |
| 650 | 7 | |a EGFR |2 Elsevier | |
| 650 | 7 | |a ddPCR |2 Elsevier | |
| 650 | 7 | |a IASLC |2 Elsevier | |
| 650 | 7 | |a EQA |2 Elsevier | |
| 650 | 7 | |a RT-PCR |2 Elsevier | |
| 650 | 7 | |a ERBB2 |2 Elsevier | |
| 650 | 7 | |a PD-L1 |2 Elsevier | |
| 650 | 7 | |a qPCR |2 Elsevier | |
| 650 | 7 | |a NTRK |2 Elsevier | |
| 650 | 7 | |a ROS1 |2 Elsevier | |
| 650 | 7 | |a ISH |2 Elsevier | |
| 650 | 7 | |a AMP |2 Elsevier | |
| 650 | 7 | |a NSCLC |2 Elsevier | |
| 650 | 7 | |a EMQN |2 Elsevier | |
| 650 | 7 | |a SOC |2 Elsevier | |
| 650 | 7 | |a ICC |2 Elsevier | |
| 650 | 7 | |a TMB |2 Elsevier | |
| 650 | 7 | |a ROSE |2 Elsevier | |
| 650 | 7 | |a BRAF |2 Elsevier | |
| 650 | 7 | |a NRG1 |2 Elsevier | |
| 650 | 7 | |a FGFR |2 Elsevier | |
| 650 | 7 | |a ESMO |2 Elsevier | |
| 650 | 7 | |a MEK |2 Elsevier | |
| 650 | 7 | |a CAP |2 Elsevier | |
| 650 | 7 | |a HER |2 Elsevier | |
| 650 | 7 | |a SOP |2 Elsevier | |
| 650 | 7 | |a FISH |2 Elsevier | |
| 650 | 7 | |a FNA |2 Elsevier | |
| 650 | 7 | |a KRAS |2 Elsevier | |
| 650 | 7 | |a MTB |2 Elsevier | |
| 650 | 7 | |a VAF |2 Elsevier | |
| 650 | 7 | |a ESCAT |2 Elsevier | |
| 650 | 7 | |a NGS |2 Elsevier | |
| 650 | 7 | |a MET |2 Elsevier | |
| 650 | 7 | |a PD-1 |2 Elsevier | |
| 650 | 7 | |a PCR |2 Elsevier | |
| 700 | 1 | |a Bibeau, Frédéric |4 oth | |
| 700 | 1 | |a Thunnissen, Erik |4 oth | |
| 700 | 1 | |a Botling, Johan |4 oth | |
| 700 | 1 | |a Ryška, Aleš |4 oth | |
| 700 | 1 | |a Wolf, Jürgen |4 oth | |
| 700 | 1 | |a Öhrling, Katarina |4 oth | |
| 700 | 1 | |a Burdon, Peter |4 oth | |
| 700 | 1 | |a Malapelle, Umberto |4 oth | |
| 700 | 1 | |a Büttner, Reinhard |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Garrote, Pedro J. ELSEVIER |t Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |d 2019 |d journal of the International Association for the Study of Lung Cancer |g Amsterdam [u.a.] |w (DE-627)ELV002331438 |
| 773 | 1 | 8 | |g volume:154 |g year:2021 |g pages:161-175 |g extent:15 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lungcan.2021.02.026 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 154 |j 2021 |h 161-175 |g 15 | ||
| author_variant |
k m k km kmk |
|---|---|
| matchkey_str |
kerrkeithmbibeaufrdricthunnissenerikbotl:2021----:heovnlnsaefimretsigonnmlc |
| hierarchy_sort_str |
2021 |
| publishDate |
2021 |
| allfields |
10.1016/j.lungcan.2021.02.026 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica (DE-627)ELV053579305 (ELSEVIER)S0169-5002(21)00086-6 DE-627 ger DE-627 rakwb eng Kerr, Keith M. verfasserin aut The evolving landscape of biomarker testing for non-small cell lung cancer in Europe 2021 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR Elsevier Bibeau, Frédéric oth Thunnissen, Erik oth Botling, Johan oth Ryška, Aleš oth Wolf, Jürgen oth Öhrling, Katarina oth Burdon, Peter oth Malapelle, Umberto oth Büttner, Reinhard oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:154 year:2021 pages:161-175 extent:15 https://doi.org/10.1016/j.lungcan.2021.02.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 154 2021 161-175 15 |
| spelling |
10.1016/j.lungcan.2021.02.026 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica (DE-627)ELV053579305 (ELSEVIER)S0169-5002(21)00086-6 DE-627 ger DE-627 rakwb eng Kerr, Keith M. verfasserin aut The evolving landscape of biomarker testing for non-small cell lung cancer in Europe 2021 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR Elsevier Bibeau, Frédéric oth Thunnissen, Erik oth Botling, Johan oth Ryška, Aleš oth Wolf, Jürgen oth Öhrling, Katarina oth Burdon, Peter oth Malapelle, Umberto oth Büttner, Reinhard oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:154 year:2021 pages:161-175 extent:15 https://doi.org/10.1016/j.lungcan.2021.02.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 154 2021 161-175 15 |
| allfields_unstemmed |
10.1016/j.lungcan.2021.02.026 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica (DE-627)ELV053579305 (ELSEVIER)S0169-5002(21)00086-6 DE-627 ger DE-627 rakwb eng Kerr, Keith M. verfasserin aut The evolving landscape of biomarker testing for non-small cell lung cancer in Europe 2021 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR Elsevier Bibeau, Frédéric oth Thunnissen, Erik oth Botling, Johan oth Ryška, Aleš oth Wolf, Jürgen oth Öhrling, Katarina oth Burdon, Peter oth Malapelle, Umberto oth Büttner, Reinhard oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:154 year:2021 pages:161-175 extent:15 https://doi.org/10.1016/j.lungcan.2021.02.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 154 2021 161-175 15 |
| allfieldsGer |
10.1016/j.lungcan.2021.02.026 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica (DE-627)ELV053579305 (ELSEVIER)S0169-5002(21)00086-6 DE-627 ger DE-627 rakwb eng Kerr, Keith M. verfasserin aut The evolving landscape of biomarker testing for non-small cell lung cancer in Europe 2021 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR Elsevier Bibeau, Frédéric oth Thunnissen, Erik oth Botling, Johan oth Ryška, Aleš oth Wolf, Jürgen oth Öhrling, Katarina oth Burdon, Peter oth Malapelle, Umberto oth Büttner, Reinhard oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:154 year:2021 pages:161-175 extent:15 https://doi.org/10.1016/j.lungcan.2021.02.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 154 2021 161-175 15 |
| allfieldsSound |
10.1016/j.lungcan.2021.02.026 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica (DE-627)ELV053579305 (ELSEVIER)S0169-5002(21)00086-6 DE-627 ger DE-627 rakwb eng Kerr, Keith M. verfasserin aut The evolving landscape of biomarker testing for non-small cell lung cancer in Europe 2021 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR Elsevier Bibeau, Frédéric oth Thunnissen, Erik oth Botling, Johan oth Ryška, Aleš oth Wolf, Jürgen oth Öhrling, Katarina oth Burdon, Peter oth Malapelle, Umberto oth Büttner, Reinhard oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:154 year:2021 pages:161-175 extent:15 https://doi.org/10.1016/j.lungcan.2021.02.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 154 2021 161-175 15 |
| language |
English |
| source |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:154 year:2021 pages:161-175 extent:15 |
| sourceStr |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:154 year:2021 pages:161-175 extent:15 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
ALK ASCO RET SGT FDA NCCN IHC TAT NEQAS OncoKB QuIP ctDNA EGFR ddPCR IASLC EQA RT-PCR ERBB2 PD-L1 qPCR NTRK ROS1 ISH AMP NSCLC EMQN SOC ICC TMB ROSE BRAF NRG1 FGFR ESMO MEK CAP HER SOP FISH FNA KRAS MTB VAF ESCAT NGS MET PD-1 PCR |
| isfreeaccess_bool |
false |
| container_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| authorswithroles_txt_mv |
Kerr, Keith M. @@aut@@ Bibeau, Frédéric @@oth@@ Thunnissen, Erik @@oth@@ Botling, Johan @@oth@@ Ryška, Aleš @@oth@@ Wolf, Jürgen @@oth@@ Öhrling, Katarina @@oth@@ Burdon, Peter @@oth@@ Malapelle, Umberto @@oth@@ Büttner, Reinhard @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002331438 |
| id |
ELV053579305 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053579305</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624195827.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2021.02.026</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053579305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(21)00086-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kerr, Keith M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The evolving landscape of biomarker testing for non-small cell lung cancer in Europe</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">15</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ALK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ASCO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SGT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FDA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NCCN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IHC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NEQAS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OncoKB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">QuIP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ctDNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ddPCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IASLC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EQA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RT-PCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ERBB2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-L1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">qPCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NTRK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROS1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ISH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NSCLC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EMQN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TMB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROSE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BRAF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NRG1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FGFR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ESMO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HER</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FISH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">KRAS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MTB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VAF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ESCAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NGS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bibeau, Frédéric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thunnissen, Erik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Botling, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ryška, Aleš</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolf, Jürgen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Öhrling, Katarina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burdon, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malapelle, Umberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büttner, Reinhard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:161-175</subfield><subfield code="g">extent:15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2021.02.026</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield><subfield code="j">2021</subfield><subfield code="h">161-175</subfield><subfield code="g">15</subfield></datafield></record></collection>
|
| author |
Kerr, Keith M. |
| spellingShingle |
Kerr, Keith M. Elsevier ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR The evolving landscape of biomarker testing for non-small cell lung cancer in Europe |
| authorStr |
Kerr, Keith M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002331438 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR Elsevier |
| topic |
Elsevier ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR |
| topic_unstemmed |
Elsevier ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR |
| topic_browse |
Elsevier ALK Elsevier ASCO Elsevier RET Elsevier SGT Elsevier FDA Elsevier NCCN Elsevier IHC Elsevier TAT Elsevier NEQAS Elsevier OncoKB Elsevier QuIP Elsevier ctDNA Elsevier EGFR Elsevier ddPCR Elsevier IASLC Elsevier EQA Elsevier RT-PCR Elsevier ERBB2 Elsevier PD-L1 Elsevier qPCR Elsevier NTRK Elsevier ROS1 Elsevier ISH Elsevier AMP Elsevier NSCLC Elsevier EMQN Elsevier SOC Elsevier ICC Elsevier TMB Elsevier ROSE Elsevier BRAF Elsevier NRG1 Elsevier FGFR Elsevier ESMO Elsevier MEK Elsevier CAP Elsevier HER Elsevier SOP Elsevier FISH Elsevier FNA Elsevier KRAS Elsevier MTB Elsevier VAF Elsevier ESCAT Elsevier NGS Elsevier MET Elsevier PD-1 Elsevier PCR |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
f b fb e t et j b jb a r ar j w jw k ö kö p b pb u m um r b rb |
| hierarchy_parent_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| hierarchy_parent_id |
ELV002331438 |
| hierarchy_top_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002331438 |
| title |
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe |
| ctrlnum |
(DE-627)ELV053579305 (ELSEVIER)S0169-5002(21)00086-6 |
| title_full |
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe |
| author_sort |
Kerr, Keith M. |
| journal |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| journalStr |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
161 |
| author_browse |
Kerr, Keith M. |
| container_volume |
154 |
| physical |
15 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Kerr, Keith M. |
| doi_str_mv |
10.1016/j.lungcan.2021.02.026 |
| title_sort |
evolving landscape of biomarker testing for non-small cell lung cancer in europe |
| title_auth |
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe |
| abstract |
• Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. |
| abstractGer |
• Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. |
| abstract_unstemmed |
• Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe |
| url |
https://doi.org/10.1016/j.lungcan.2021.02.026 |
| remote_bool |
true |
| author2 |
Bibeau, Frédéric Thunnissen, Erik Botling, Johan Ryška, Aleš Wolf, Jürgen Öhrling, Katarina Burdon, Peter Malapelle, Umberto Büttner, Reinhard |
| author2Str |
Bibeau, Frédéric Thunnissen, Erik Botling, Johan Ryška, Aleš Wolf, Jürgen Öhrling, Katarina Burdon, Peter Malapelle, Umberto Büttner, Reinhard |
| ppnlink |
ELV002331438 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.lungcan.2021.02.026 |
| up_date |
2024-07-06T19:20:01.946Z |
| _version_ |
1803858583955177472 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053579305</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624195827.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2021.02.026</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001347.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053579305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(21)00086-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kerr, Keith M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The evolving landscape of biomarker testing for non-small cell lung cancer in Europe</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">15</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Molecular testing determines appropriate targeted therapies for advanced NSCLC. • Country-specific differences exist in molecular testing availability across Europe. • Molecular tumour board and reflex molecular testing strategies are desirable. • Next-generation sequencing permits comprehensive molecular testing. • Cell-free DNA-based analysis facilitates re-testing to guide subsequent treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ALK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ASCO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SGT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FDA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NCCN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IHC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NEQAS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OncoKB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">QuIP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ctDNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ddPCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IASLC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EQA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RT-PCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ERBB2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-L1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">qPCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NTRK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROS1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ISH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NSCLC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EMQN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TMB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROSE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BRAF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NRG1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FGFR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ESMO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HER</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FISH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">KRAS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MTB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VAF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ESCAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NGS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PCR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bibeau, Frédéric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thunnissen, Erik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Botling, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ryška, Aleš</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolf, Jürgen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Öhrling, Katarina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burdon, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malapelle, Umberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büttner, Reinhard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:161-175</subfield><subfield code="g">extent:15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2021.02.026</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield><subfield code="j">2021</subfield><subfield code="h">161-175</subfield><subfield code="g">15</subfield></datafield></record></collection>
|
| score |
7.398053 |